New findings raise HRT risks
Sales of supplements for menopause symptoms are likely to surge in coming months, after a major UK study finds that combination hormone replacement therapy (HRT) could double the risk of breast cancer.
News, Analysis & Insights on Nutrition, Supplements, and Health
Sales of supplements for menopause symptoms are likely to surge in coming months, after a major UK study finds that combination hormone replacement therapy (HRT) could double the risk of breast cancer.
Products containing the herb Chelidonium majus should include a warning label to consumers, Australia's Complementary Medicines Evaluation Committee has advised.
Newly-formed Acatris is planning a major assault on the UK market and has predicted that Britain will be among the top three growth markets for its health ingredients.